Utilizing next-generation sequencing to characterize a case of acute myeloid leukemia with t(4;12)(q12;p13) in the absence of ETV6/CHIC2 and ETV6/PDGFRA gene fusions.

[1]  A. Iafrate,et al.  t(4;12)(q12;p13) ETV6-rearranged AML without eosinophilia does not involve PDGFRA: relevance for imatinib insensitivity , 2021, Blood advances.

[2]  Sarah H. Johnson,et al.  Characterizing false-positive fluorescence in situ hybridization results by mate-pair sequencing in a patient with chronic myeloid leukemia and progression to myeloid blast crisis. , 2020, Cancer genetics.

[3]  Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2 , 2020, Definitions.

[4]  P. L. Bergsagel,et al.  Mate pair sequencing outperforms fluorescence in situ hybridization in the genomic characterization of multiple myeloma , 2019, Blood Cancer Journal.

[5]  J. Smadbeck,et al.  Identification of a Novel ZBTB20-JAK2 Fusion by Mate-Pair Sequencing in a Young Adult With B-Lymphoblastic Leukemia/Lymphoma. , 2019, Mayo Clinic proceedings.

[6]  Sarah H. Johnson,et al.  Mate pair sequencing improves detection of genomic abnormalities in acute myeloid leukemia , 2018, European journal of haematology.

[7]  Travis M. Drucker,et al.  SVAtools for junction detection of genome-wide chromosomal rearrangements by mate-pair sequencing (MPseq). , 2018, Cancer genetics.

[8]  T. Matsui,et al.  A novel FOXP1-PDGFRA fusion gene in myeloproliferative neoplasm with eosinophilia. , 2015, Cancer genetics.

[9]  R. Yelensky,et al.  Comprehensive genomic profiling identifies a novel TNKS2–PDGFRA fusion that defines a myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy , 2015, Blood Cancer Journal.

[10]  Travis M. Drucker,et al.  BIMA V3: an aligner customized for mate pair library sequencing , 2014, Bioinform..

[11]  H. Kantarjian,et al.  Imatinib therapy in a patient with suspected chronic neutrophilic leukemia and FIP1L1-PDGFRA rearrangement. , 2013, Blood.

[12]  N. Cross,et al.  Myeloid neoplasm with rearrangement of PDGFRA, but with no significant eosinophilia: should we broaden the World Health Organization definition of the entity? , 2012, British journal of haematology.

[13]  A. Reiter,et al.  Two novel imatinib‐responsive PDGFRA fusion genes in chronic eosinophilic leukaemia , 2007, British journal of haematology.

[14]  N. Schmitz,et al.  Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma , 2007, Leukemia.

[15]  W. Hiddemann,et al.  A rare case of acute myeloid leukemia with a CHIC2-ETV6 fusiongen and multiple other molecular aberrations , 2005, Leukemia.

[16]  P. Marynen,et al.  Evidence for position effects as a variant ETV6-mediated leukemogenic mechanism in myeloid leukemias with a t(4;12)(q11-q12;p13) or t(5;12)(q31;p13). , 2002, Blood.

[17]  P. Marynen,et al.  Fusion of a novel gene, BTL, to ETV6 in acute myeloid leukemias with a t(4;12)(q11-q12;p13). , 1999, Blood.